{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:11:00Z","timestamp":1792725060168,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["VA ESP Project #05-226"],"award-info":[{"award-number":["VA ESP Project #05-226"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13643-017-0635-z","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T11:47:58Z","timestamp":1515584878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review"],"prefix":"10.1186","volume":"7","author":[{"given":"Christopher P.","family":"Childers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Maggard-Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus G.","family":"Ulloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian T.","family":"MacQueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isomi M.","family":"Miake-Lye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Shanman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Beroes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Shekelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"635_CR1","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1001\/jama.2013.278787","volume":"310","author":"MT Hawn","year":"2013","unstructured":"Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013;310:1462\u201372.","journal-title":"JAMA"},{"key":"635_CR2","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S0735-1097(00)00521-0","volume":"35","author":"GL Kaluza","year":"2000","unstructured":"Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35:1288\u201394.","journal-title":"J Am Coll Cardiol"},{"key":"635_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.amjcard.2009.06.038","volume":"104","author":"JP van Kuijk","year":"2009","unstructured":"van Kuijk JP, Flu WJ, Schouten O, Hoeks SE, Schenkeveld L, de Jaegere PP, Bax JJ, van Domburg RT, Serruys PW, Poldermans D. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol. 2009;104:1229\u201334.","journal-title":"Am J Cardiol"},{"key":"635_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0735-1097(03)00622-3","volume":"42","author":"SH Wilson","year":"2003","unstructured":"Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol. 2003;42:234\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"152","key":"635_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","volume":"2016","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, et al. ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016;2016(152):1243\u201375.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"635_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.carrev.2009.09.007","volume":"12","author":"T Khair","year":"2011","unstructured":"Khair T, Garcia B, Banerjee S, Brilakis ES. Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists. Cardiovasc Revasc Med. 2011;12:99\u2013104.","journal-title":"Cardiovasc Revasc Med"},{"key":"635_CR7","unstructured":"Maggard Gibbons M, Ulloa JG, Macqueen I, Childers CP, Miake-Lye IM, Shanman R, Beroes JM, Shekelle PG. Management of Antiplatelet Therapy among Patients on Antiplatelet Therapy for Coronary or Cerebrovascular Disease or with Prior Percutaneous Cardiac Interventions Undergoing Elective Surgery: A Systematic Review. VA ESP Project #05- 226; 201."},{"key":"635_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med."},{"key":"635_CR9","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/hrt.2011.224519","volume":"97","author":"P Albaladejo","year":"2011","unstructured":"Albaladejo P, Marret E, Samama CM, Collet JP, Abhay K, Loutrel O, Charbonneau H, Jaber S, Thoret S, Bosson JL, Piriou V. Non-cardiac surgery in patients with coronary stents: the RECO study. Heart. 2011;97:1566\u201372.","journal-title":"Heart"},{"key":"635_CR10","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.jacc.2012.04.062","volume":"60","author":"S Singla","year":"2012","unstructured":"Singla S, Sachdeva R, Uretsky BF. The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention. J Am Coll Cardiol. 2012;60:2005\u201316.","journal-title":"J Am Coll Cardiol"},{"key":"635_CR11","unstructured":"JPT H, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]: The Cochrane Collaboration; 2011. Available from \n                    http:\/\/training.cochrane.org\/handbook\n                    \n                  ."},{"key":"635_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280\u20136.","journal-title":"Ann Intern Med"},{"key":"635_CR13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"635_CR14","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736\u201347.","journal-title":"Circulation"},{"key":"635_CR15","doi-asserted-by":"publisher","first-page":"E527","DOI":"10.1055\/s-0042-102649","volume":"4","author":"G Egholm","year":"2016","unstructured":"Egholm G, Thim T, Madsen M, Sorensen HT, Pedersen JB, Eggert Jensen S, Jensen LO, Kristensen SD, Botker HE, Maeng M. Gastroscopy-related adverse cardiac events and bleeding complications among patients treated with coronary stents and dual antiplatelet therapy. Endosc Int Open. 2016;4:E527\u201333.","journal-title":"Endosc Int Open"},{"key":"635_CR16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ccd.22158","volume":"74","author":"A Assali","year":"2009","unstructured":"Assali A, Vaknin-Assa H, Lev E, Bental T, Ben-Dor I, Teplitsky I, Brosh D, Fuchs S, Eidelman L, Battler A, Kornowski R. The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery. Catheter Cardiovasc Interv. 2009;74:837\u201343.","journal-title":"Catheter Cardiovasc Interv"},{"key":"635_CR17","first-page":"283","volume":"23","author":"IA Bolad","year":"2011","unstructured":"Bolad IA, Alqaqa'a A, Khan B, Srivastav SK, von der Lohe E, Sadanandan S, Breall JA. Cardiac events after non-cardiac surgery in patients with previous coronary intervention in the drug-eluting stent era. J Invasive Cardiol. 2011;23:283\u20136.","journal-title":"J Invasive Cardiol"},{"key":"635_CR18","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.amjsurg.2015.05.036","volume":"211","author":"EW Chu","year":"2016","unstructured":"Chu EW, Chernoguz A, Divino CM. The evaluation of clopidogrel use in perioperative general surgery patients: a prospective randomized controlled trial. Am J Surg. 2016;211:1019\u201325.","journal-title":"Am J Surg"},{"key":"635_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4244\/EIJV9I2A35","volume":"9","author":"LI Alshawabkeh","year":"2013","unstructured":"Alshawabkeh LI, Prasad A, Lenkovsky F, Makary LF, Kandil ES, Weideman RA, Kelly KC, Rangan BV, Banerjee S, Brilakis ES. Outcomes of a preoperative \u201cbridging\u201d strategy with glycoprotein IIb\/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration. EuroIntervention. 2013;9:204\u201311.","journal-title":"EuroIntervention"},{"key":"635_CR20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/0310057X0703500613","volume":"35","author":"M Conroy","year":"2007","unstructured":"Conroy M, Bolsin SN, Black SA, Orford N. Perioperative complications in patients with drug-eluting stents: a three-year audit at Geelong Hospital. Anaesth Intensive Care. 2007;35:939\u201344.","journal-title":"Anaesth Intensive Care"},{"key":"635_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12471-011-0197-y","volume":"19","author":"EG Marcos","year":"2011","unstructured":"Marcos EG, Da Fonseca AC, Hofma SH. Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation. Neth Heart J. 2011;19:412\u20137.","journal-title":"Neth Heart J"},{"key":"635_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1160\/TH14-12-1057","volume":"114","author":"D Capodanno","year":"2015","unstructured":"Capodanno D, Musumeci G, Lettieri C, Limbruno U, Senni M, Guagliumi G, Valsecchi O, Angiolillo DJ, Rossini R. Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery. Thromb Haemost. 2015;114:423\u201331.","journal-title":"Thromb Haemost"},{"key":"635_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11748-011-0775-3","volume":"59","author":"M Sonobe","year":"2011","unstructured":"Sonobe M, Sato T, Chen F, Fujinaga T, Shoji T, Sakai H, Miyahara R, Bando T, Huang CL, Date H. Management of patients with coronary stents in elective thoracic surgery. Gen Thorac Cardiovasc Surg. 2011;59:477\u201382.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"635_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2169\/internalmedicine.55.5495","volume":"55","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Ishii H, Tatami Y, Shibata Y, Osugi N, Ota T, Kawamura Y, Suzuki S, Nagao Y, Matsushita T, Murohara T. Unfractionated heparin during the interruption of antiplatelet therapy for non-cardiac surgery after drug-eluting stent implantation. Intern Med. 2016;55:333\u20137.","journal-title":"Intern Med"},{"key":"635_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijcard.2008.10.050","volume":"139","author":"CU Choi","year":"2010","unstructured":"Choi CU, Rha SW, Jin Z, Chen KY, Minami Y, Kim JH, Na JO, Suh SY, Kim JW, Kim EJ, et al. The optimal timing for non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents. Int J Cardiol. 2010;139:313\u20136.","journal-title":"Int J Cardiol"},{"key":"635_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/jhm.227","volume":"2","author":"DJ Brotman","year":"2007","unstructured":"Brotman DJ, Bakhru M, Saber W, Aneja A, Bhatt DL, Tillan-Martinez K, Jaffer AK. Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study. J Hosp Med. 2007;2:378\u201384.","journal-title":"J Hosp Med"},{"key":"635_CR27","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1016\/j.ijcard.2013.12.114","volume":"172","author":"A Tanaka","year":"2014","unstructured":"Tanaka A, Sakakibara M, Ishii H, Okumura S, Suzuki S, Inoue Y, Jinno Y, Okada K, Murohara T. The risk of adverse cardiac events following minor surgery under discontinuation of all antiplatelet therapy in patients with prior drug-eluting stent implantation. Int J Cardiol. 2014;172:e125\u20136.","journal-title":"Int J Cardiol"},{"key":"635_CR28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jtcvs.2010.07.051","volume":"140","author":"RJ Cerfolio","year":"2010","unstructured":"Cerfolio RJ, Minnich DJ, Bryant AS. General thoracic surgery is safe in patients taking clopidogrel (Plavix). J Thorac Cardiovasc Surg. 2010;140:970\u20136.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"635_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0140-6736(15)60243-4","volume":"386","author":"JL Mega","year":"2015","unstructured":"Mega JL, Simon T. Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments. Lancet. 2015;386:281\u201391.","journal-title":"Lancet"},{"issue":"64","key":"635_CR30","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.jacc.2014.07.944","volume":"2014","author":"LA Fleisher","year":"2014","unstructured":"Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, et al. ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;2014(64):e77\u2013137.","journal-title":"J Am Coll Cardiol"},{"key":"635_CR31","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"635_CR32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jjcc.2014.02.027","volume":"64","author":"K Yamamoto","year":"2014","unstructured":"Yamamoto K, Wada H, Sakakura K, Ikeda N, Yamada Y, Katayama T, Sugawara Y, Mitsuhashi T, Ako J, Momomura S. Cardiovascular and bleeding risk of non-cardiac surgery in patients on antiplatelet therapy. J Cardiol. 2014;64:334\u20138.","journal-title":"J Cardiol"},{"key":"635_CR33","doi-asserted-by":"crossref","unstructured":"The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673\u201382.","DOI":"10.1056\/NEJM199309023291001"},{"key":"635_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","volume":"76","author":"JH Chesebro","year":"1987","unstructured":"Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, et al. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987;76:142\u201354.","journal-title":"Circulation"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-017-0635-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-017-0635-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-017-0635-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T14:14:12Z","timestamp":1589552052000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-017-0635-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["635"],"URL":"https:\/\/doi.org\/10.1186\/s13643-017-0635-z","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"assertion":[{"value":"10 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was considered exempt by the VA Greater Los Angeles Healthcare System Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Paul G. Shekelle is the editor-in-chief for BMC Systematic Reviews. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"4"}}